MYCN and neoplasm: In tumours with MYCN amplification and hence a worse prognosis, the oncogene is able to downregulate the expression of TrkA through binding with the transcription factors SP1 and MYZ1, forming a complex that recruits a histone deacetylase, HDAC1, which induces a repressed chromatin state [50].